Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients

NCT00654186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Revlimid

Sponsor

Oncology Specialists, S.C.

Collaborators

[object Object]